{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:09:49Z","timestamp":1778926189058,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20lk1403038"],"award-info":[{"award-number":["JP20lk1403038"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H03841"],"award-info":[{"award-number":["20H03841"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.xops.2022.100152","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T12:34:42Z","timestamp":1649248482000},"page":"100152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8195-6287","authenticated-orcid":false,"given":"Nao","family":"Aisu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7410-3764","authenticated-orcid":false,"given":"Masahiro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikatsu","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7603-9954","authenticated-orcid":false,"given":"Ayako","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Ueda-Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7574-1749","authenticated-orcid":false,"given":"Manabu","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0977-9458","authenticated-orcid":false,"given":"Akio","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7740-2732","authenticated-orcid":false,"given":"Hiroshi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotaro","family":"Ooto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9354-8558","authenticated-orcid":false,"given":"Kenji","family":"Yamashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitaka","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2022.100152_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: a review of epidemiology and pathophysiology","volume":"41","author":"Liew","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2022.100152_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.47102\/annals-acadmedsg.V35N2p77","article-title":"Angiographic characteristics of acute central serous chorioretinopathy in an Asian population","volume":"35","author":"How","year":"2006","journal-title":"Ann Acad Med Singap"},{"key":"10.1016\/j.xops.2022.100152_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2021.100033","article-title":"Distribution of choroidal thickness and choroidal vessel dilation in healthy Japanese individuals","volume":"1","author":"Mori","year":"2021","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2022.100152_bib4","article-title":"Incidence of central serous chorioretinopathy (2011-2018): a nationwide population-based cohort study of Japan","author":"Kido","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2022.100152_bib5","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","article-title":"Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy","volume":"126","author":"Mrejen","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2022.100152_bib6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s42003-019-0712-z","article-title":"Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy","volume":"2","author":"Hosoda","year":"2019","journal-title":"Commun Biol"},{"key":"10.1016\/j.xops.2022.100152_bib7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.oret.2019.05.025","article-title":"Predictive genes for the prognosis of central serous chorioretinopathy","volume":"3","author":"Hosoda","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2022.100152_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/srep16204","article-title":"Pachychoroid neovasculopathy and age-related macular degeneration","volume":"5","author":"Miyake","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2022.100152_bib9","doi-asserted-by":"crossref","first-page":"18423","DOI":"10.1038\/s41598-020-75451-5","article-title":"Deep phenotype unsupervised machine learning revealed the significance of pachychoroid features in etiology and visual prognosis of age-related macular degeneration","volume":"10","author":"Hosoda","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2022.100152_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/IAE.0000000000001138","article-title":"Comparison of photodynamic therapy using half-dose of verteporfin or half-fluence of laser light for the treatment of chronic central serous chorioretinopathy","volume":"37","author":"Cheng","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.xops.2022.100152_bib11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajo.2014.01.022","article-title":"Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy","volume":"157","author":"Nicolo","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2022.100152_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IAE.0b013e3181e378f2","article-title":"Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"31","author":"Shin","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.xops.2022.100152_bib13","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","article-title":"Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial","volume":"115","author":"Chan","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2022.100152_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13063-015-0939-z","article-title":"Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial","volume":"16","author":"Breukink","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.xops.2022.100152_bib15","first-page":"684","article-title":"The effect of bronchitis, smoking, and occupation on ventilation","volume":"87","author":"Brinkman","year":"1963","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.xops.2022.100152_bib16","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00417-019-04333-y","article-title":"Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage","volume":"257","author":"van Rijssen","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2022.100152_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0161-6420(92)31981-5","article-title":"Digital indocyanine-green angilography in chorioretinal disorders","volume":"99","author":"Guyer","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2022.100152_bib18","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1167\/iovs.14-14059","article-title":"Choroidal neovascularization in eyes with choroidal vascular hyperpermeability","volume":"55","author":"Miyake","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2022.100152_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ophtha.2014.09.034","article-title":"One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy","volume":"122","author":"Fujita","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2022.100152_bib20","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.xops.2022.100152_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.xops.2022.100152_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/aje\/kwj047","article-title":"Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect","volume":"163","author":"Kurth","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.xops.2022.100152_bib23","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.xops.2022.100152_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.xops.2022.100152_bib25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/resp.12312","article-title":"Introduction to propensity scores","volume":"19","author":"Williamson","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.xops.2022.100152_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-000953","article-title":"Three handy tips and a practical guide to improve your propensity score models","volume":"5","author":"Bergstra","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.xops.2022.100152_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"10.1016\/j.xops.2022.100152_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011841","article-title":"Interventions for central serous chorioretinopathy: a network meta-analysis","author":"Salehi","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xops.2022.100152_bib29","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: The PLACE Trial","volume":"125","author":"van Dijk","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2022.100152_bib30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2013.09.024","article-title":"Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial","volume":"121","author":"Bae","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2022.100152_bib31","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s10384-012-0162-3","article-title":"Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy","volume":"56","author":"Semeraro","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.xops.2022.100152_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jamaophthalmol.2014.5312","article-title":"A\u00a050% vs. 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial","volume":"133","author":"Zhao","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2022.100152_bib33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/CCM.0000000000000150","article-title":"Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis","volume":"42","author":"Iwagami","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.xops.2022.100152_bib34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","article-title":"Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial","volume":"41","author":"Payen","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.xops.2022.100152_bib35","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2018.14618","article-title":"Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES Randomized Clinical Trial","volume":"320","author":"Dellinger","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.xops.2022.100152_bib36","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9394(02)01825-1","article-title":"A\u00a0computerized method of visual acuity testing","volume":"135","author":"Beck","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2022.100152_bib37","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1038\/ctg.2013.13","article-title":"A\u00a0primer on effectiveness and efficacy trials","volume":"5","author":"Singal","year":"2014","journal-title":"Clin Transl Gastroenterol"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914522000410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914522000410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:37:28Z","timestamp":1778924248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914522000410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2666914522000410"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2022.100152","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2022.100152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100152"}}